Company Filing History:
Years Active: 2013-2014
Title: Hsiao-Li Wu: Innovator in Biotechnology
Introduction
Hsiao-Li Wu is a prominent inventor based in Tainan, Taiwan. He has made significant contributions to the field of biotechnology, particularly in the development of methods and strains that enhance health outcomes.
Latest Patents
Hsiao-Li Wu holds two notable patents. The first patent is titled "Method for enhancing PPARγ expression." This invention provides a method for enhancing PPARγ expression by administering an effective amount of PM-A0005, which has been deposited under the Budapest Treaty in the China Center for Type Culture Collection (CCTCC), China, with Deposition No. M 207039. The second patent is focused on "Strains of lactic acid bacteria for preventing necrotizing enterocolitis." This invention relates to novel strains of lactic acid bacteria, including subsp. PM-A0087 deposited as NRRL accession number B-50523, PM-A0101 deposited as NRRL accession number B-50525, and PM-A0218 deposited as NRRL accession number B-50524.
Career Highlights
Hsiao-Li Wu is associated with Promd Biotech Co., Ltd., where he continues to innovate and contribute to advancements in biotechnology. His work has been instrumental in developing solutions that address critical health issues.
Collaborations
Hsiao-Li Wu collaborates with several talented individuals, including Wei-Chih Su and Hsiang Ling Chen. These collaborations enhance the research and development efforts within his field.
Conclusion
Hsiao-Li Wu's contributions to biotechnology through his patents and collaborations highlight his role as an influential inventor. His work continues to pave the way for advancements in health-related technologies.